GeneTech Inc. has been acquired by Eurofins
Noritsu Koki Co., Ltd. has sold GeneTech Inc. to Eurofins Clinical Testing Holding Lux S.à r.l.
GeneTech is a provider of non-invasive prenatal genetic tests (NIPT). The tests can only be taken at facilities certified by the Japanese Association of Medical Sciences. As a result of these efforts, GeneTech has carried out more than 90% of the NIPT tests conducted in Japan. Additionally, based on the achievements and experience accumulated, the firm has delivered various academic information and peripheral services to medical institutions.
Incorporated in 2014, Eurofins Clinical Testing Holding Lux S.à r.l. is a global clinical test service provider based in Luxembourg.
Founded in 1951, Noritsu Koki is a Tokyo Stock First Section listed public conglomerate specializing in manufacturing and healthcare businesses.
Oaklins’ team in Japan acted as the exclusive financial advisor to Noritsu Koki Co., Ltd. in this transaction.
Talk to the deal team
Managing DirectorTokyo, Japan
ScreenPoint Medical has raised US$28 million in a Series C investment round led by Insight Partners
Netherlands-based ScreenPoint Medical, an AI technology company that develops advanced image recognition and machine learning software to improve early detection of breast cancer, has raised US$28 million (€24 million) in a Series C funding round led by New York-based global venture capital and private equity firm Insight Partners to further develop its technology and accelerate commercial growth of the company’s Transpara AI breast care software.Learn more
Intergrin has raised financing provided by Kartesia
Intergrin has obtained a unitranche loan of approximately US$59 million to refinance existing debt and to further support the growth of different healthcare and well-being initiatives.Learn more
MediCA klinika acquires G. Radavičiaus klinika
MediCA klinika has acquired G. Radavičiaus klinika.Learn more